WC
PRAH

Weil Company’s PRA Health Sciences, Inc. PRAH Stock Holding History

Weil Company’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-588
Closed -$58K – 377
2019
Q3 		$58K Buy
+588
New +$58.4K 0.04% 182

Other funds holding PRAH

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
NIPH
NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return

Weil Company's PRAH Position: Q4 2019 in Review

Weil Company sold out of PRA Health Sciences, Inc. (PRAH) in Q4 2019, closing a stake of 588 shares — an estimated $58K sold.

Weil Company first reported a position in PRAH in Q3 2019 and held it in 1 quarter. The position peaked at $58K in Q3 2019. 345 funds tracked by Wall St. Rank hold PRAH as of Q4 2019.

  • Weil Company reported no remaining PRA Health Sciences, Inc. position as of Q4 2019 after selling out during the quarter.
  • Weil Company sold 588 PRA Health Sciences, Inc. shares in Q4 2019, an estimated $58K.
  • Weil Company first reported a position in PRA Health Sciences, Inc. in Q3 2019 and held it in 1 quarter.
  • Weil Company's PRA Health Sciences, Inc. position peaked at $58K in Q3 2019.
  • 345 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q4 2019.

Based on Weil Company's 13F filing for Q4 2019, filed 13 Feb 2020.